Oncotarget-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=545503, encodeId=915b5455036b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：接受所有医学生物学基础和临床研究，分数不错，要求不算苛刻，可以尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0ad1612667, createdName=lvlvdl, createdTime=Mon Aug 14 20:21:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545498, encodeId=2817545498af, content=一般清样以后多久先online?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5121925286, createdName=Erosxing, createdTime=Mon Aug 14 19:11:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545496, encodeId=b61754549685, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：文章online后多久才能在web of science上查询到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f512110734, createdName=cuiqin0704@, createdTime=Mon Aug 14 17:32:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545488, encodeId=9a7c5454880e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：希望心系一处, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31731733253, createdName=C~shiftc3e0816e, createdTime=Mon Aug 14 16:02:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545482, encodeId=1b33545482df, content=谢谢你呀！Dr.？？？ 2017-08-11 发表:: 签在一张上，只用签第一和通讯, beContent=Dr.？？？ 2017-08-11 发表:: 签在一张上，只用签第一和通讯, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/21/62f26f50128c7bb3718164e41f453433.jpg, createdBy=98471681992, createdName=月半月半, createdTime=Mon Aug 14 13:29:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545472, encodeId=14565454e2e6, content=杂志投稿链接怎么无法登入，是不让投稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Mon Aug 14 09:40:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545451, encodeId=fcce545451be, content=这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e41724470, createdName=njjna, createdTime=Sun Aug 13 11:13:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545452, encodeId=450e545452ee, content=收的njjna 2017-08-13 发表:: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？njjna 2017-08-13 11:13:00 发表: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, beContent=njjna 2017-08-13 发表:: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/20/a03e3cf18cc705a6dff3eabb4f8a39a7.jpg, createdBy=07cf1725867, createdName=POWERJIE, createdTime=Sun Aug 13 00:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545453, encodeId=1dae545453b3, content=我看到了，谢谢你malon2009 2017-08-12 发表:: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了malon2009 2017-08-12 00:00:00 发表: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了, beContent=malon2009 2017-08-12 发表:: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/20/a03e3cf18cc705a6dff3eabb4f8a39a7.jpg, createdBy=07cf1725867, createdName=POWERJIE, createdTime=Sun Aug 13 00:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545430, encodeId=7b07545430f9, content=大家不要乱来，2016年是5.168, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat Aug 12 16:22:00 CST 2017, time=2017-08-12, status=1, ipAttribution=)]

2017-08-14 lvlvdl

审稿速度:3.0 | 投稿命中率:75.0
经验分享：接受所有医学生物学基础和临床研究，分数不错，要求不算苛刻，可以尝试。

63 0

[GetPortalCommentsPageByObjectIdResponse(id=545503, encodeId=915b5455036b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：接受所有医学生物学基础和临床研究，分数不错，要求不算苛刻，可以尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0ad1612667, createdName=lvlvdl, createdTime=Mon Aug 14 20:21:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545498, encodeId=2817545498af, content=一般清样以后多久先online?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5121925286, createdName=Erosxing, createdTime=Mon Aug 14 19:11:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545496, encodeId=b61754549685, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：文章online后多久才能在web of science上查询到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f512110734, createdName=cuiqin0704@, createdTime=Mon Aug 14 17:32:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545488, encodeId=9a7c5454880e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：希望心系一处, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31731733253, createdName=C~shiftc3e0816e, createdTime=Mon Aug 14 16:02:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545482, encodeId=1b33545482df, content=谢谢你呀！Dr.？？？ 2017-08-11 发表:: 签在一张上，只用签第一和通讯, beContent=Dr.？？？ 2017-08-11 发表:: 签在一张上，只用签第一和通讯, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/21/62f26f50128c7bb3718164e41f453433.jpg, createdBy=98471681992, createdName=月半月半, createdTime=Mon Aug 14 13:29:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545472, encodeId=14565454e2e6, content=杂志投稿链接怎么无法登入，是不让投稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Mon Aug 14 09:40:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545451, encodeId=fcce545451be, content=这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e41724470, createdName=njjna, createdTime=Sun Aug 13 11:13:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545452, encodeId=450e545452ee, content=收的njjna 2017-08-13 发表:: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？njjna 2017-08-13 11:13:00 发表: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, beContent=njjna 2017-08-13 发表:: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/20/a03e3cf18cc705a6dff3eabb4f8a39a7.jpg, createdBy=07cf1725867, createdName=POWERJIE, createdTime=Sun Aug 13 00:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545453, encodeId=1dae545453b3, content=我看到了，谢谢你malon2009 2017-08-12 发表:: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了malon2009 2017-08-12 00:00:00 发表: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了, beContent=malon2009 2017-08-12 发表:: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/20/a03e3cf18cc705a6dff3eabb4f8a39a7.jpg, createdBy=07cf1725867, createdName=POWERJIE, createdTime=Sun Aug 13 00:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545430, encodeId=7b07545430f9, content=大家不要乱来，2016年是5.168, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat Aug 12 16:22:00 CST 2017, time=2017-08-12, status=1, ipAttribution=)]

2017-08-14 Erosxing

一般清样以后多久先online?

64 0

[GetPortalCommentsPageByObjectIdResponse(id=545503, encodeId=915b5455036b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：接受所有医学生物学基础和临床研究，分数不错，要求不算苛刻，可以尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0ad1612667, createdName=lvlvdl, createdTime=Mon Aug 14 20:21:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545498, encodeId=2817545498af, content=一般清样以后多久先online?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5121925286, createdName=Erosxing, createdTime=Mon Aug 14 19:11:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545496, encodeId=b61754549685, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：文章online后多久才能在web of science上查询到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f512110734, createdName=cuiqin0704@, createdTime=Mon Aug 14 17:32:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545488, encodeId=9a7c5454880e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：希望心系一处, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31731733253, createdName=C~shiftc3e0816e, createdTime=Mon Aug 14 16:02:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545482, encodeId=1b33545482df, content=谢谢你呀！Dr.？？？ 2017-08-11 发表:: 签在一张上，只用签第一和通讯, beContent=Dr.？？？ 2017-08-11 发表:: 签在一张上，只用签第一和通讯, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/21/62f26f50128c7bb3718164e41f453433.jpg, createdBy=98471681992, createdName=月半月半, createdTime=Mon Aug 14 13:29:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545472, encodeId=14565454e2e6, content=杂志投稿链接怎么无法登入，是不让投稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Mon Aug 14 09:40:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545451, encodeId=fcce545451be, content=这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e41724470, createdName=njjna, createdTime=Sun Aug 13 11:13:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545452, encodeId=450e545452ee, content=收的njjna 2017-08-13 发表:: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？njjna 2017-08-13 11:13:00 发表: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, beContent=njjna 2017-08-13 发表:: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/20/a03e3cf18cc705a6dff3eabb4f8a39a7.jpg, createdBy=07cf1725867, createdName=POWERJIE, createdTime=Sun Aug 13 00:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545453, encodeId=1dae545453b3, content=我看到了，谢谢你malon2009 2017-08-12 发表:: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了malon2009 2017-08-12 00:00:00 发表: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了, beContent=malon2009 2017-08-12 发表:: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/20/a03e3cf18cc705a6dff3eabb4f8a39a7.jpg, createdBy=07cf1725867, createdName=POWERJIE, createdTime=Sun Aug 13 00:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545430, encodeId=7b07545430f9, content=大家不要乱来，2016年是5.168, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat Aug 12 16:22:00 CST 2017, time=2017-08-12, status=1, ipAttribution=)]

2017-08-14 cuiqin0704@

审稿速度:3.0 | 投稿命中率:50.0
经验分享：文章online后多久才能在web of science上查询到

63 0

[GetPortalCommentsPageByObjectIdResponse(id=545503, encodeId=915b5455036b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：接受所有医学生物学基础和临床研究，分数不错，要求不算苛刻，可以尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0ad1612667, createdName=lvlvdl, createdTime=Mon Aug 14 20:21:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545498, encodeId=2817545498af, content=一般清样以后多久先online?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5121925286, createdName=Erosxing, createdTime=Mon Aug 14 19:11:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545496, encodeId=b61754549685, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：文章online后多久才能在web of science上查询到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f512110734, createdName=cuiqin0704@, createdTime=Mon Aug 14 17:32:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545488, encodeId=9a7c5454880e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：希望心系一处, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31731733253, createdName=C~shiftc3e0816e, createdTime=Mon Aug 14 16:02:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545482, encodeId=1b33545482df, content=谢谢你呀！Dr.？？？ 2017-08-11 发表:: 签在一张上，只用签第一和通讯, beContent=Dr.？？？ 2017-08-11 发表:: 签在一张上，只用签第一和通讯, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/21/62f26f50128c7bb3718164e41f453433.jpg, createdBy=98471681992, createdName=月半月半, createdTime=Mon Aug 14 13:29:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545472, encodeId=14565454e2e6, content=杂志投稿链接怎么无法登入，是不让投稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Mon Aug 14 09:40:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545451, encodeId=fcce545451be, content=这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e41724470, createdName=njjna, createdTime=Sun Aug 13 11:13:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545452, encodeId=450e545452ee, content=收的njjna 2017-08-13 发表:: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？njjna 2017-08-13 11:13:00 发表: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, beContent=njjna 2017-08-13 发表:: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/20/a03e3cf18cc705a6dff3eabb4f8a39a7.jpg, createdBy=07cf1725867, createdName=POWERJIE, createdTime=Sun Aug 13 00:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545453, encodeId=1dae545453b3, content=我看到了，谢谢你malon2009 2017-08-12 发表:: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了malon2009 2017-08-12 00:00:00 发表: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了, beContent=malon2009 2017-08-12 发表:: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/20/a03e3cf18cc705a6dff3eabb4f8a39a7.jpg, createdBy=07cf1725867, createdName=POWERJIE, createdTime=Sun Aug 13 00:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545430, encodeId=7b07545430f9, content=大家不要乱来，2016年是5.168, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat Aug 12 16:22:00 CST 2017, time=2017-08-12, status=1, ipAttribution=)]

2017-08-14 C~shiftc3e0816e

审稿速度:3.0 | 投稿命中率:25.0
经验分享：希望心系一处

51 0

[GetPortalCommentsPageByObjectIdResponse(id=545503, encodeId=915b5455036b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：接受所有医学生物学基础和临床研究，分数不错，要求不算苛刻，可以尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0ad1612667, createdName=lvlvdl, createdTime=Mon Aug 14 20:21:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545498, encodeId=2817545498af, content=一般清样以后多久先online?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5121925286, createdName=Erosxing, createdTime=Mon Aug 14 19:11:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545496, encodeId=b61754549685, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：文章online后多久才能在web of science上查询到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f512110734, createdName=cuiqin0704@, createdTime=Mon Aug 14 17:32:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545488, encodeId=9a7c5454880e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：希望心系一处, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31731733253, createdName=C~shiftc3e0816e, createdTime=Mon Aug 14 16:02:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545482, encodeId=1b33545482df, content=谢谢你呀！Dr.？？？ 2017-08-11 发表:: 签在一张上，只用签第一和通讯, beContent=Dr.？？？ 2017-08-11 发表:: 签在一张上，只用签第一和通讯, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/21/62f26f50128c7bb3718164e41f453433.jpg, createdBy=98471681992, createdName=月半月半, createdTime=Mon Aug 14 13:29:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545472, encodeId=14565454e2e6, content=杂志投稿链接怎么无法登入，是不让投稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Mon Aug 14 09:40:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545451, encodeId=fcce545451be, content=这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e41724470, createdName=njjna, createdTime=Sun Aug 13 11:13:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545452, encodeId=450e545452ee, content=收的njjna 2017-08-13 发表:: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？njjna 2017-08-13 11:13:00 发表: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, beContent=njjna 2017-08-13 发表:: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/20/a03e3cf18cc705a6dff3eabb4f8a39a7.jpg, createdBy=07cf1725867, createdName=POWERJIE, createdTime=Sun Aug 13 00:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545453, encodeId=1dae545453b3, content=我看到了，谢谢你malon2009 2017-08-12 发表:: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了malon2009 2017-08-12 00:00:00 发表: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了, beContent=malon2009 2017-08-12 发表:: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/20/a03e3cf18cc705a6dff3eabb4f8a39a7.jpg, createdBy=07cf1725867, createdName=POWERJIE, createdTime=Sun Aug 13 00:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545430, encodeId=7b07545430f9, content=大家不要乱来，2016年是5.168, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat Aug 12 16:22:00 CST 2017, time=2017-08-12, status=1, ipAttribution=)]

2017-08-14 月半月半

谢谢你呀！Dr.？？？ 2017-08-11 发表::
签在一张上，只用签第一和通讯

Dr.？？？ 2017-08-11 发表:: 签在一张上，只用签第一和通讯

58 0

[GetPortalCommentsPageByObjectIdResponse(id=545503, encodeId=915b5455036b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：接受所有医学生物学基础和临床研究，分数不错，要求不算苛刻，可以尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0ad1612667, createdName=lvlvdl, createdTime=Mon Aug 14 20:21:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545498, encodeId=2817545498af, content=一般清样以后多久先online?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5121925286, createdName=Erosxing, createdTime=Mon Aug 14 19:11:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545496, encodeId=b61754549685, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：文章online后多久才能在web of science上查询到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f512110734, createdName=cuiqin0704@, createdTime=Mon Aug 14 17:32:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545488, encodeId=9a7c5454880e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：希望心系一处, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31731733253, createdName=C~shiftc3e0816e, createdTime=Mon Aug 14 16:02:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545482, encodeId=1b33545482df, content=谢谢你呀！Dr.？？？ 2017-08-11 发表:: 签在一张上，只用签第一和通讯, beContent=Dr.？？？ 2017-08-11 发表:: 签在一张上，只用签第一和通讯, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/21/62f26f50128c7bb3718164e41f453433.jpg, createdBy=98471681992, createdName=月半月半, createdTime=Mon Aug 14 13:29:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545472, encodeId=14565454e2e6, content=杂志投稿链接怎么无法登入，是不让投稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Mon Aug 14 09:40:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545451, encodeId=fcce545451be, content=这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e41724470, createdName=njjna, createdTime=Sun Aug 13 11:13:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545452, encodeId=450e545452ee, content=收的njjna 2017-08-13 发表:: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？njjna 2017-08-13 11:13:00 发表: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, beContent=njjna 2017-08-13 发表:: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/20/a03e3cf18cc705a6dff3eabb4f8a39a7.jpg, createdBy=07cf1725867, createdName=POWERJIE, createdTime=Sun Aug 13 00:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545453, encodeId=1dae545453b3, content=我看到了，谢谢你malon2009 2017-08-12 发表:: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了malon2009 2017-08-12 00:00:00 发表: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了, beContent=malon2009 2017-08-12 发表:: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/20/a03e3cf18cc705a6dff3eabb4f8a39a7.jpg, createdBy=07cf1725867, createdName=POWERJIE, createdTime=Sun Aug 13 00:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545430, encodeId=7b07545430f9, content=大家不要乱来，2016年是5.168, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat Aug 12 16:22:00 CST 2017, time=2017-08-12, status=1, ipAttribution=)]

2017-08-14 futuremaster

杂志投稿链接怎么无法登入，是不让投稿了吗？

65 0

[GetPortalCommentsPageByObjectIdResponse(id=545503, encodeId=915b5455036b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：接受所有医学生物学基础和临床研究，分数不错，要求不算苛刻，可以尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0ad1612667, createdName=lvlvdl, createdTime=Mon Aug 14 20:21:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545498, encodeId=2817545498af, content=一般清样以后多久先online?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5121925286, createdName=Erosxing, createdTime=Mon Aug 14 19:11:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545496, encodeId=b61754549685, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：文章online后多久才能在web of science上查询到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f512110734, createdName=cuiqin0704@, createdTime=Mon Aug 14 17:32:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545488, encodeId=9a7c5454880e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：希望心系一处, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31731733253, createdName=C~shiftc3e0816e, createdTime=Mon Aug 14 16:02:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545482, encodeId=1b33545482df, content=谢谢你呀！Dr.？？？ 2017-08-11 发表:: 签在一张上，只用签第一和通讯, beContent=Dr.？？？ 2017-08-11 发表:: 签在一张上，只用签第一和通讯, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/21/62f26f50128c7bb3718164e41f453433.jpg, createdBy=98471681992, createdName=月半月半, createdTime=Mon Aug 14 13:29:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545472, encodeId=14565454e2e6, content=杂志投稿链接怎么无法登入，是不让投稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Mon Aug 14 09:40:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545451, encodeId=fcce545451be, content=这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e41724470, createdName=njjna, createdTime=Sun Aug 13 11:13:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545452, encodeId=450e545452ee, content=收的njjna 2017-08-13 发表:: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？njjna 2017-08-13 11:13:00 发表: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, beContent=njjna 2017-08-13 发表:: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/20/a03e3cf18cc705a6dff3eabb4f8a39a7.jpg, createdBy=07cf1725867, createdName=POWERJIE, createdTime=Sun Aug 13 00:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545453, encodeId=1dae545453b3, content=我看到了，谢谢你malon2009 2017-08-12 发表:: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了malon2009 2017-08-12 00:00:00 发表: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了, beContent=malon2009 2017-08-12 发表:: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/20/a03e3cf18cc705a6dff3eabb4f8a39a7.jpg, createdBy=07cf1725867, createdName=POWERJIE, createdTime=Sun Aug 13 00:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545430, encodeId=7b07545430f9, content=大家不要乱来，2016年是5.168, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat Aug 12 16:22:00 CST 2017, time=2017-08-12, status=1, ipAttribution=)]

2017-08-13 njjna

这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？

57 0

[GetPortalCommentsPageByObjectIdResponse(id=545503, encodeId=915b5455036b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：接受所有医学生物学基础和临床研究，分数不错，要求不算苛刻，可以尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0ad1612667, createdName=lvlvdl, createdTime=Mon Aug 14 20:21:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545498, encodeId=2817545498af, content=一般清样以后多久先online?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5121925286, createdName=Erosxing, createdTime=Mon Aug 14 19:11:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545496, encodeId=b61754549685, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：文章online后多久才能在web of science上查询到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f512110734, createdName=cuiqin0704@, createdTime=Mon Aug 14 17:32:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545488, encodeId=9a7c5454880e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：希望心系一处, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31731733253, createdName=C~shiftc3e0816e, createdTime=Mon Aug 14 16:02:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545482, encodeId=1b33545482df, content=谢谢你呀！Dr.？？？ 2017-08-11 发表:: 签在一张上，只用签第一和通讯, beContent=Dr.？？？ 2017-08-11 发表:: 签在一张上，只用签第一和通讯, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/21/62f26f50128c7bb3718164e41f453433.jpg, createdBy=98471681992, createdName=月半月半, createdTime=Mon Aug 14 13:29:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545472, encodeId=14565454e2e6, content=杂志投稿链接怎么无法登入，是不让投稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Mon Aug 14 09:40:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545451, encodeId=fcce545451be, content=这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e41724470, createdName=njjna, createdTime=Sun Aug 13 11:13:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545452, encodeId=450e545452ee, content=收的njjna 2017-08-13 发表:: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？njjna 2017-08-13 11:13:00 发表: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, beContent=njjna 2017-08-13 发表:: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/20/a03e3cf18cc705a6dff3eabb4f8a39a7.jpg, createdBy=07cf1725867, createdName=POWERJIE, createdTime=Sun Aug 13 00:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545453, encodeId=1dae545453b3, content=我看到了，谢谢你malon2009 2017-08-12 发表:: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了malon2009 2017-08-12 00:00:00 发表: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了, beContent=malon2009 2017-08-12 发表:: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/20/a03e3cf18cc705a6dff3eabb4f8a39a7.jpg, createdBy=07cf1725867, createdName=POWERJIE, createdTime=Sun Aug 13 00:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545430, encodeId=7b07545430f9, content=大家不要乱来，2016年是5.168, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat Aug 12 16:22:00 CST 2017, time=2017-08-12, status=1, ipAttribution=)]

2017-08-13 POWERJIE

收的njjna 2017-08-13 发表::
这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？njjna 2017-08-13 11:13:00 发表:
这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？

njjna 2017-08-13 发表:: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？

61 0

[GetPortalCommentsPageByObjectIdResponse(id=545503, encodeId=915b5455036b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：接受所有医学生物学基础和临床研究，分数不错，要求不算苛刻，可以尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0ad1612667, createdName=lvlvdl, createdTime=Mon Aug 14 20:21:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545498, encodeId=2817545498af, content=一般清样以后多久先online?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5121925286, createdName=Erosxing, createdTime=Mon Aug 14 19:11:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545496, encodeId=b61754549685, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：文章online后多久才能在web of science上查询到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f512110734, createdName=cuiqin0704@, createdTime=Mon Aug 14 17:32:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545488, encodeId=9a7c5454880e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：希望心系一处, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31731733253, createdName=C~shiftc3e0816e, createdTime=Mon Aug 14 16:02:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545482, encodeId=1b33545482df, content=谢谢你呀！Dr.？？？ 2017-08-11 发表:: 签在一张上，只用签第一和通讯, beContent=Dr.？？？ 2017-08-11 发表:: 签在一张上，只用签第一和通讯, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/21/62f26f50128c7bb3718164e41f453433.jpg, createdBy=98471681992, createdName=月半月半, createdTime=Mon Aug 14 13:29:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545472, encodeId=14565454e2e6, content=杂志投稿链接怎么无法登入，是不让投稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Mon Aug 14 09:40:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545451, encodeId=fcce545451be, content=这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e41724470, createdName=njjna, createdTime=Sun Aug 13 11:13:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545452, encodeId=450e545452ee, content=收的njjna 2017-08-13 发表:: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？njjna 2017-08-13 11:13:00 发表: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, beContent=njjna 2017-08-13 发表:: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/20/a03e3cf18cc705a6dff3eabb4f8a39a7.jpg, createdBy=07cf1725867, createdName=POWERJIE, createdTime=Sun Aug 13 00:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545453, encodeId=1dae545453b3, content=我看到了，谢谢你malon2009 2017-08-12 发表:: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了malon2009 2017-08-12 00:00:00 发表: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了, beContent=malon2009 2017-08-12 发表:: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/20/a03e3cf18cc705a6dff3eabb4f8a39a7.jpg, createdBy=07cf1725867, createdName=POWERJIE, createdTime=Sun Aug 13 00:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545430, encodeId=7b07545430f9, content=大家不要乱来，2016年是5.168, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat Aug 12 16:22:00 CST 2017, time=2017-08-12, status=1, ipAttribution=)]

2017-08-13 POWERJIE

我看到了，谢谢你malon2009 2017-08-12 发表::
在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了malon2009 2017-08-12 00:00:00 发表:
在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了

malon2009 2017-08-12 发表:: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了

116 0

[GetPortalCommentsPageByObjectIdResponse(id=545503, encodeId=915b5455036b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：接受所有医学生物学基础和临床研究，分数不错，要求不算苛刻，可以尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0ad1612667, createdName=lvlvdl, createdTime=Mon Aug 14 20:21:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545498, encodeId=2817545498af, content=一般清样以后多久先online?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5121925286, createdName=Erosxing, createdTime=Mon Aug 14 19:11:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545496, encodeId=b61754549685, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：文章online后多久才能在web of science上查询到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f512110734, createdName=cuiqin0704@, createdTime=Mon Aug 14 17:32:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545488, encodeId=9a7c5454880e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：希望心系一处, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31731733253, createdName=C~shiftc3e0816e, createdTime=Mon Aug 14 16:02:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545482, encodeId=1b33545482df, content=谢谢你呀！Dr.？？？ 2017-08-11 发表:: 签在一张上，只用签第一和通讯, beContent=Dr.？？？ 2017-08-11 发表:: 签在一张上，只用签第一和通讯, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/21/62f26f50128c7bb3718164e41f453433.jpg, createdBy=98471681992, createdName=月半月半, createdTime=Mon Aug 14 13:29:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545472, encodeId=14565454e2e6, content=杂志投稿链接怎么无法登入，是不让投稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61711620830, createdName=futuremaster, createdTime=Mon Aug 14 09:40:00 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545451, encodeId=fcce545451be, content=这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82e41724470, createdName=njjna, createdTime=Sun Aug 13 11:13:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545452, encodeId=450e545452ee, content=收的njjna 2017-08-13 发表:: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？njjna 2017-08-13 11:13:00 发表: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, beContent=njjna 2017-08-13 发表:: 这杂志是不是只接受肿瘤相关的，不是肿瘤的其他疾病基础研究收不收？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/20/a03e3cf18cc705a6dff3eabb4f8a39a7.jpg, createdBy=07cf1725867, createdName=POWERJIE, createdTime=Sun Aug 13 00:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545453, encodeId=1dae545453b3, content=我看到了，谢谢你malon2009 2017-08-12 发表:: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了malon2009 2017-08-12 00:00:00 发表: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了, beContent=malon2009 2017-08-12 发表:: 在投稿须知里查找参考文献格式要求印象中好像是有提供链接可以下载格式文件然后再导入endnote就可以用了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/20/a03e3cf18cc705a6dff3eabb4f8a39a7.jpg, createdBy=07cf1725867, createdName=POWERJIE, createdTime=Sun Aug 13 00:00:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545430, encodeId=7b07545430f9, content=大家不要乱来，2016年是5.168, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat Aug 12 16:22:00 CST 2017, time=2017-08-12, status=1, ipAttribution=)]

2017-08-12 lovetcm

大家不要乱来，2016年是5.168

74 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务